Floatz logo

NEPENTHE

Sarcopenia

Central Taiwan University of Science and TechnologySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

4 Active assets in the Sarcopenia cohort.

Asset / SponsorPhaseRating
Theprubicin
Sohag University
D
Ethiodized Oil
Sohag University
D
METAMIZOLE
Central Taiwan University of Science and Technology
N/AD
Humulin R
University of Nottingham
N/AD
DEXKETOPROFEN
Central Taiwan University of Science and Technology
N/AD
Alpha Tocopherol
University of Ioannina
N/AD
PANITUMUMAB
Consorci Sanitari del Maresme
N/AD
Iodixanol
Nemocnice AGEL Trinec-Podlesi a.s.
D

Same molecule, other indications

NEPENTHE is also rated in:

PainDormant
BBB
Indicative ·
77 / 100
View asset →
cancer of unknown primary siteDormant
BBB
Indicative ·
75 / 100
View asset →
chronic pain syndromeDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →